NHS: Innovation

Department of Health written question – answered on 2nd December 2015.

Alert me about debates like this

Photo of Andrew Gwynne Andrew Gwynne Shadow Minister (Health)

To ask the Secretary of State for Health, what assessment his Department has made of the effect of Innovation Health and Wealth on patient access to innovative new medicines and technologies.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

The Department is funding RAND Europe and the University of Manchester to conduct a formative and summative evaluation of Innovation, Health and Wealth. The project is expected to complete in 2017, the report on the first stage of the evaluation is due to be published imminently. Further details can be found on the RAND Europe website:

www.rand.org/randeurope/research/projects/innovation-health-wealth.html

Since the publication of One Year On in 2012, an update on the implementation of the Innovation Health and Wealth (IHW) report, there has been a great deal of progress made in many of the IHW work streams. Much of this has been incorporated into NHS England’s Innovation Into Action: Supporting delivery of the NHS Five Year Funding View, published in September 2015 and can be found at:

https://www.england.nhs.uk/wp-content/uploads/2015/10/nhs-inovation-into-action.pdf

The Department and NHS England remain committed to driving improvements in health through developing, testing and spreading innovation across the health system. For example, NHS England developed an Innovation Scorecard to track the uptake of medicines positively appraised by the National Institute for Health and Care Excellence. The data is published by the Health and Social Care Information Centre at national, regional, hospital trust and Clinical Commissioning Group level for various drugs and medical devices, where information is readily available. Work is underway with industry to expand the number of medical devices included in the publication and industry data is incorporated where companies have regularly provided it. The scorecard helps the NHS understand variation in uptake across England, demonstrated through benchmarking “heat maps”, and is a tool for enabling discussions between commissioners and providers to improve the uptake of medicines for NHS patients.

Does this answer the above question?

Yes0 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.